Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours

International Journal of Cancer

Volumn 88, Issue 1, 2000, Pages 66-70

  Zwahlen, Daniel ^a   Tschan, Mario P ^a   Grob, Tobias J ^a   Peters, Uwe R ^b   Fink, Daniel ^c   Haenggi, Willy ^a   Altermatt, Hans J ^d   Cajot, Jean François ^a   Tobler, Andreas ^a   Fey, Martin F ^a   Aebi, Stefan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Pathologie Länggasse   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P73;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033864175     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001001)88:1<66::AID-IJC10>3.0.CO;2-Y     Document Type: Article

References (37)

1. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis
2. Mdm2 binds p73alpha without targeting degradation
3. Human ovarian cancer of the surface epithelium
4. Allelic expression of p73 in human ovarian cancers
5. Induction of neuronal differentiation by p73 in a neuroblastoma cell line
6. Additional complexity in p73: Induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta
7. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
8. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
9. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
10. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
11. p53 family genes: Structural comparison, expression and mutation
12. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target
13. p73 is a human p53-related protein that can induce apoptosis
14. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
15. Fortnightly review: Hereditary ovarian carcinoma
16. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation
17. Promoter specificity and stability control of the p53-related protein p73
18. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions
19. Structure, function and regulation of p63 and p73
20. A non-radioactive method for inexpensive quantitative RT-PCR
21. Activation of p73 silent allele in lung cancer
22. Analysis of p73 in human borderline and invasive ovarian tumor
23. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers
24. Lonely no more: p53 finds its kin in a tumor suppressor haven
25. Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis
26. Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines
27. Mutational analysis of the p73 gene in human breast cancers
28. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma
29. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma
30. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma
31. New p73 variants with altered C-terminal structures have varied transcriptional activities
32. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line
33. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
34. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
35. Over-expression of the wild type p73 gene in breast cancer tissues and cell lines
36. The potential tumor suppressor p73 differentially regulates cellular p53 target genes